Christian Mobs

Marburg An Der Lahn, HE, Germany

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 59 publications

Successful tolerance induction by allergen immunotherapy in a patient with bee venom anaphylaxis under treatment with a Janus kinase 1/2 inhibitor.

Successful tolerance induction by allergen immunotherapy in a patient with bee venom anaphylaxis under treatment with a Janus kinase 1/2 inhibitor.

Journal: The journal of allergy and clinical immunology. In practice

Published: April 28, 2025

Safety, tolerability, pharmacokinetics and pharmacodynamic effects of desmoglein 3 peptide-coupled tolerizing nanoparticles in pemphigus.

Safety, tolerability, pharmacokinetics and pharmacodynamic effects of desmoglein 3 peptide-coupled tolerizing nanoparticles in pemphigus.

Journal: The British journal of dermatology

Published: March 12, 2025

Deep Analysis of Desmoglein-3-Reactive CD4+ T Cells in Pemphigus Vulgaris Reveals a Type 17/Type 2 T-Cell Signature.

Deep Analysis of Desmoglein-3-Reactive CD4+ T Cells in Pemphigus Vulgaris Reveals a Type 17/Type 2 T-Cell Signature.

Journal: The Journal of investigative dermatology

Published: January 06, 2025

Follicular T-helper cells in bullous pemphigoid: how polarization affects the pathophysiology of B-cell-mediated autoimmune diseases.

Follicular T-helper cells in bullous pemphigoid: how polarization affects the pathophysiology of B-cell-mediated autoimmune diseases.

Journal: The British journal of dermatology

Published: October 13, 2024

Booster Injection with Birch Pollen Extract Activates B-Cellular Memory Responses in Patients Having Completed Allergen Immunotherapy.

Booster Injection with Birch Pollen Extract Activates B-Cellular Memory Responses in Patients Having Completed Allergen Immunotherapy.

Journal: European journal of immunology

Published: June 03, 2024

A type I interferon regulatory network for human plasmacytoid dendritic cells based on heparin, membrane-bound and soluble BDCA-2.

A type I interferon regulatory network for human plasmacytoid dendritic cells based on heparin, membrane-bound and soluble BDCA-2.

Journal: Proceedings of the National Academy of Sciences of the United States of America

Published: March 13, 2024

Pathogenic relevance of antibodies against desmoglein 3 in patients with oral lichen planus.

Pathogenic relevance of antibodies against desmoglein 3 in patients with oral lichen planus.

Journal: Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG

Published: February 01, 2024

EAACI task force report: A consensus protocol for the basophil activation test for collaboration and external quality assurance.

EAACI task force report: A consensus protocol for the basophil activation test for collaboration and external quality assurance.

Journal: Allergy

Published: July 25, 2023

Nanobody-based IgG simultaneously inhibit the allergenic and enzymatic activity of the dominant honeybee venom allergen.

Nanobody-based IgG simultaneously inhibit the allergenic and enzymatic activity of the dominant honeybee venom allergen.

Journal: Nature communications

Published: July 11, 2023

Extracellular vesicles: Messengers of allergic immune responses and novel therapeutic strategy.

Extracellular vesicles: Messengers of allergic immune responses and novel therapeutic strategy.

Journal: European journal of immunology

Published: June 30, 2023

Ganzkörper-Blaulichtbestrahlung zur Behandlung der atopischen Dermatitis: eine randomisierte, placebokontrollierte klinische Studie (AD-Blue).

Ganzkörper-Blaulichtbestrahlung zur Behandlung der atopischen Dermatitis: eine randomisierte, placebokontrollierte klinische Studie (AD-Blue).

Journal: Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG

Published: February 10, 2023

Full-body blue light irradiation as treatment for atopic dermatitis: a randomized sham-controlled clinical trial (AD-Blue).

Full-body blue light irradiation as treatment for atopic dermatitis: a randomized sham-controlled clinical trial (AD-Blue).

Journal: Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG

Published: February 10, 2023

Showing 1-12 of 59

Last Updated: 09/26/2026